The European Commission’s proposal to codify legitimate interest as a legal basis for AI training marks the most significant reform to the GDPR since its adoption. By explicitly recognizing legitimate interest as legal basis for AI training, the Commission aims to reconcile data protection with the realities of modern artificial intelligence.
Artificial intelligence is rapidly transforming the life sciences sector — and its impact on the medical devices industry is particularly significant, especially after the coming into force of the EU AI Act. From diagnostics to patient monitoring and personalized treatments, AI-powered medical technologies are reshaping the future of healthcare in Italy, Europe, and globally. But as innovation accelerates, so does the need for a robust legal framework — especially under the recently adopted AI Act.
